PSkarbek
TL3 Regular · Vigo, ES
Laboratory background. Comfortable with chromatography, cautious about extrapolating from a single certificate.
Joined 3 November 2024 · last posted 23h · groups: analytical-chemists
139Posts here
4Topics
0Solutions
5.8kLikes received
5.9kLikes given
33Badges
484Days visited
18kPosts read
Stated areas
Recent activity
Full stream-
[2026 update] Comparing prices across jurisdictions without misleading yourself Replied, post #3 · Access › Pricing · 27 Jul 2026 · 0 likes Biosimilars and future generics: as patents expire, biosimilar and generic versions might become available and prices might fall. That has already happened for some…
-
Follow-up: Reading an interaction checker output critically Replied, post #67 · Practice › Interactions · 26 Jul 2026 · 12 likes Everything in post #63 holds. The case it does not cover is the one I have. Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K)…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #89 · Meta › Announcements · 24 Jul 2026 · 13 likes Confirming post #86 from a second method, which matters more than confirming it from a second person. What I would tell a new member reading about Trust level 3…
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #49 · Compounds › Secretagogues & GH axis · 19 Jul 2026 · 27 likes The reason Reading a rodent study keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is unknown.
-
Shakes versus food: a pragmatic assessment Replied, post #24 · Nutrition & Training › Protein & intake · 15 Jul 2026 · 8 likes Shakes versus food: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would like to…
-
What a certificate commits its issuer to — one year on Replied, post #108 · Analytics › COA interpretation · 13 Jul 2026 · 0 likes "Not less than 98 per cent" is a specification. "98.3 per cent" is a result. A certificate carrying only the first has not told you what was measured.
-
Coming back to: Batch date after test date, and other internal inconsistencies Replied, post #7 · Analytics › COA interpretation · 8 Jul 2026 · 15 likes This follows post #6 rather than contradicting it. An itemised related-substances table with retention times says considerably more about the synthesis than a single…
-
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #18 · Clinical › Comorbidities · 2 Jul 2026 · 23 likes I read the earlier replies on Type 2 diabetes twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what was said…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #80 · Start Here › How to Ask · 28 Jun 2026 · 28 likes Picking up post #79: that is the part I would want checked first. A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the…
-
Tracking intake honestly when appetite is absent Replied, post #76 · Nutrition & Training › Protein & intake · 27 Jun 2026 · 0 likes Eating anything at all: on substantial appetite suppression, eating enough total calories to maintain lean mass is the priority. Protein comes second to total intake.
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #89 · Safety › Contraindications · 27 Jun 2026 · 12 likes Somebody's condition being on a list does not settle the decision, and somebody's condition being absent from one does not either. This has been discussed before and I…
-
Selection into a registry and what it does to the estimate — a second dataset Started this topic · Evidence › Study critique · 25 Jun 2026 · 3 likes Posting this under the heading it deserves: Selection into a registry and what it does to the estimate — a second dataset Everything below is what sits behind that.…
Maintains 5 documents
- Tirzepatide — referenceReview due 10 Jan 2027
- CagriSema — referenceReview due 6 Oct 2026
- TB-500 — referenceReview due 3 Oct 2026
- Peak integration in practiceReview due 21 Dec 2026
- Bacterial endotoxin testingReview due 26 Feb 2027